Earnings PerformanceRevenue of $95 million was down 8% year-over-year, even though management expected first-quarter revenue to be flat on the fourth-quarter call.
Guidance WithdrawalFollowing a much weaker-than-expected Q1 report, DDD withdrew its 2025 revenue guidance, citing the potential for ongoing cautious customer capital spending.
Healthcare Business DeclineThe weak Q1 top-line performance included a 9% decline in the company’s Healthcare business, driven mainly by a large 32% year-over-year revenue decline at the company’s large dental orthodontics customer.